PALAK PATEL: Open Payments
NPI 1104313386 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 29 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $39 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $158 |
| E.R. Squibb & Sons, L.L.C. | 5 | $105 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| Esperion Therapeutics, Inc. | 2 | $46 |
| Amgen Inc. | 3 | $46 |
| AngioDynamics, Inc. | 2 | $39 |
| PFIZER INC. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $24 |
Products named: VERQUVO, ELIQUIS, CAMZYOS, JARDIANCE, ONPATTRO, NEXLETOL, REPATHA, ALPHAVAC.
Industry payments across OK — which companies pay providers there.
